Event

This webinar is for Clinical Outcome Assessment (COA) scientists involved in developing COA strategies to generate evidence for stakeholders such as regulatory bodies, reimbursement agencies, clinicians, and patients. The webinar will also be of benefit to those interested in learning how COA data can be valued by multiple stakeholders. The discussion will focus on the challenges with developing robust Patient Reported Outcome (PRO) strategies to effectively meet the needs of all stakeholders. Additionally, it will discuss the forthcoming recommendations from SISAQOL-IMI, an international multi-stakeholder Consortium, concerning the design, analysis, and communication of PROs. 

Presenters will discuss the value of PRO data from different stakeholder perspectives and explore how SISAQOL-IMI recommendations are likely to impact their practices. More specifically, the webinar will discuss the challenges of evaluating PRO data from an HTA and regulatory perspective, reflecting the different evidentiary requirements for submissions to different HTA bodies and regulatory authorities. An industry perspective on how the SISAQOL-IMI recommendations would impact the industry practices regarding PROs will be presented. The webinar will also cover patient perspective on PROs and how patients and patient representatives are planning to use the SISAQOL-IMI recommendations. 

Hans Scheurer, MSc, Vice Chair, Workgroup of European Cancer Patient Advocacy Networks (WECAN), Nijmegen, Netherlands